Cargando…

The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer

(1) Background. Breast cancer is the leading cancer type among women. Despite convenient diagnostics at early stages, there is a need for continuous monitoring to predict more aggressive or recurring breast cancer forms. The evidence suggests that the detection of genetic biomarkers could help in im...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartnykaitė, Agnė, Savukaitytė, Aistė, Bekampytė, Justina, Ugenskienė, Rasa, Laukaitienė, Danguolė, Korobeinikova, Erika, Gudaitienė, Jurgita, Juozaitytė, Elona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405670/
https://www.ncbi.nlm.nih.gov/pubmed/36009438
http://dx.doi.org/10.3390/biomedicines10081891
_version_ 1784773934770552832
author Bartnykaitė, Agnė
Savukaitytė, Aistė
Bekampytė, Justina
Ugenskienė, Rasa
Laukaitienė, Danguolė
Korobeinikova, Erika
Gudaitienė, Jurgita
Juozaitytė, Elona
author_facet Bartnykaitė, Agnė
Savukaitytė, Aistė
Bekampytė, Justina
Ugenskienė, Rasa
Laukaitienė, Danguolė
Korobeinikova, Erika
Gudaitienė, Jurgita
Juozaitytė, Elona
author_sort Bartnykaitė, Agnė
collection PubMed
description (1) Background. Breast cancer is the leading cancer type among women. Despite convenient diagnostics at early stages, there is a need for continuous monitoring to predict more aggressive or recurring breast cancer forms. The evidence suggests that the detection of genetic biomarkers could help in improving disease management and reduce mortality. Matrix metalloproteinases (MMPs) are a large family of enzymes that perform physiologically relevant functions and have the potential properties to be biomarkers for cancer assessment. We aimed to evaluate the contribution and association of single-nucleotide polymorphisms (SNPs) in MMP genes (MMP1, MMP2, MMP3, MMP7, MMP8, MMP9) with clinicopathological breast-cancer features. (2) Methods. In this study, 100 breast cancer patients were genotyped by polymerase chain reaction–restriction fragment length polymorphism methodology (PCR–RFLP). (3) Results. The presence of the MMP7 rs11568818 A allele was associated with lower chances for poorly differentiated breast cancer. The lower possibility for HER2-positive breast cancer was associated with the presence of the MMP9 rs3918242 C allele. (4) Conclusions. These results indicate that MMP7 rs11568818 and MMP9 rs3918242 are potential biomarkers for the anticipation of breast cancer aggressiveness.
format Online
Article
Text
id pubmed-9405670
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94056702022-08-26 The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer Bartnykaitė, Agnė Savukaitytė, Aistė Bekampytė, Justina Ugenskienė, Rasa Laukaitienė, Danguolė Korobeinikova, Erika Gudaitienė, Jurgita Juozaitytė, Elona Biomedicines Article (1) Background. Breast cancer is the leading cancer type among women. Despite convenient diagnostics at early stages, there is a need for continuous monitoring to predict more aggressive or recurring breast cancer forms. The evidence suggests that the detection of genetic biomarkers could help in improving disease management and reduce mortality. Matrix metalloproteinases (MMPs) are a large family of enzymes that perform physiologically relevant functions and have the potential properties to be biomarkers for cancer assessment. We aimed to evaluate the contribution and association of single-nucleotide polymorphisms (SNPs) in MMP genes (MMP1, MMP2, MMP3, MMP7, MMP8, MMP9) with clinicopathological breast-cancer features. (2) Methods. In this study, 100 breast cancer patients were genotyped by polymerase chain reaction–restriction fragment length polymorphism methodology (PCR–RFLP). (3) Results. The presence of the MMP7 rs11568818 A allele was associated with lower chances for poorly differentiated breast cancer. The lower possibility for HER2-positive breast cancer was associated with the presence of the MMP9 rs3918242 C allele. (4) Conclusions. These results indicate that MMP7 rs11568818 and MMP9 rs3918242 are potential biomarkers for the anticipation of breast cancer aggressiveness. MDPI 2022-08-04 /pmc/articles/PMC9405670/ /pubmed/36009438 http://dx.doi.org/10.3390/biomedicines10081891 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bartnykaitė, Agnė
Savukaitytė, Aistė
Bekampytė, Justina
Ugenskienė, Rasa
Laukaitienė, Danguolė
Korobeinikova, Erika
Gudaitienė, Jurgita
Juozaitytė, Elona
The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
title The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
title_full The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
title_fullStr The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
title_full_unstemmed The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
title_short The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer
title_sort role of matrix metalloproteinase single-nucleotide polymorphisms in the clinicopathological properties of breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405670/
https://www.ncbi.nlm.nih.gov/pubmed/36009438
http://dx.doi.org/10.3390/biomedicines10081891
work_keys_str_mv AT bartnykaiteagne theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT savukaityteaiste theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT bekampytejustina theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT ugenskienerasa theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT laukaitienedanguole theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT korobeinikovaerika theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT gudaitienejurgita theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT juozaityteelona theroleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT bartnykaiteagne roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT savukaityteaiste roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT bekampytejustina roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT ugenskienerasa roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT laukaitienedanguole roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT korobeinikovaerika roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT gudaitienejurgita roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer
AT juozaityteelona roleofmatrixmetalloproteinasesinglenucleotidepolymorphismsintheclinicopathologicalpropertiesofbreastcancer